After Vaccine Support, India, South Africa Likely to Demand Waiver of Patent on Covid-19 Drugs and Medical Tools

After Vaccine Support, India, South Africa Likely to Demand Waiver of Patent on Covid-19 Drugs and Medical Tools
News18
2 hours ago
News18
© Provided by News18
After Vaccine Support, India, South Africa Likely to Demand Waiver of Patent on Covid-19 Drugs and Medical Tools
After getting US support on the waiver of patents on vaccines, South Africa, India, and other developing countries are likely to demand TRIPS (Trade-Related Aspects of Intellectual Property Rights) waiver for Covid-19 drugs and medical tools too.
According to an exclusive report by Times of India, with US Trade Representative indicating American support only for talks on patent flexibility for vaccines at the WTO, the scope of the proposed waiver could turn out to be the next sticking point. In October, India and South Africa had submitted a joint proposal, which had just outlined the broad areas of TRIPS waiver. The revised draft will provide the scope, in terms of coverage as well as the duration, which could be longer than originally expected.

Related Keywords

South Africa ,United States ,India ,American , ,World Trade Organization ,After Vaccine Support ,South Africa Likely ,Demand Waiver ,Vaccine Support ,Medical Tools ,Trade Related Aspects ,Intellectual Property Rights ,Big Pharma ,ஒன்றுபட்டது மாநிலங்களில் ,இந்தியா ,அமெரிக்கன் ,உலகம் வர்த்தகம் ஆர்கநைஸேஶந் ,தடுப்பூசி ஆதரவு ,மருத்துவ கருவிகள் ,வர்த்தகம் தொடர்புடையது அம்சங்கள் ,அறிவுசார் ப்ராபர்டீ உரிமைகள் ,பெரியது பார்மா ,